• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinicopathological Spectrum of Breast Cancer Patients Presenting at a Tertiary Care Hospital in Sindh, Pakistan.巴基斯坦信德省一家三级护理医院收治的乳腺癌患者的临床病理特征
Cureus. 2025 Jun 17;17(6):e86249. doi: 10.7759/cureus.86249. eCollection 2025 Jun.
2
Interplay of Receptor Status, Age, and Stage in Breast Cancer: A Prospective Analysis.乳腺癌中受体状态、年龄和分期的相互作用:一项前瞻性分析。
Cureus. 2025 Jun 13;17(6):e85925. doi: 10.7759/cureus.85925. eCollection 2025 Jun.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.免疫组织化学检测切除修复交叉互补基因1(ERCC1)对三阴性乳腺癌新辅助化疗反应的预测价值
Breast J. 2025 Feb 18;2025:8410670. doi: 10.1155/tbj/8410670. eCollection 2025.
6
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Clinicopathological and molecular subtypes of breast cancer in the Eastern Cape, South Africa: A two-year retrospective study.南非东开普省乳腺癌的临床病理和分子亚型:一项为期两年的回顾性研究。
PLoS One. 2025 Jul 21;20(7):e0325387. doi: 10.1371/journal.pone.0325387. eCollection 2025.
9
Are Detailed, Patient-level Social Determinant of Health Factors Associated With Physical Function and Mental Health at Presentation Among New Patients With Orthopaedic Conditions?详细的患者层面的健康社会决定因素是否与新骨科患者就诊时的身体功能和心理健康相关?
Clin Orthop Relat Res. 2023 May 1;481(5):912-921. doi: 10.1097/CORR.0000000000002446. Epub 2022 Oct 6.
10
The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.发展中国家乳腺癌新辅助化疗的实际情况:来自印度一家三级癌症中心的 80 例乳腺癌报告。
J Cancer Res Clin Oncol. 2014 Oct;140(10):1777-82. doi: 10.1007/s00432-014-1724-1. Epub 2014 Jun 4.

本文引用的文献

1
Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.管腔B型、人表皮生长因子受体2(HER2/neu)型和三阴性乳腺癌在新辅助治疗后比管腔A型乳腺癌具有更好的化疗反应。
Cureus. 2023 Jun 6;15(6):e40066. doi: 10.7759/cureus.40066. eCollection 2023 Jun.
2
CORRELATION BETWEEN HEPCIDIN AND PROCALCITONIN AND THEIR DIAGNOSTIC ROLE IN PATIENTS WITH COVID-19.铁调素与降钙素原的相关性及其在 COVID-19 患者中的诊断作用。
Wiad Lek. 2023;76(1):65-70. doi: 10.36740/WLek202301109.
3
The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01).解剖分期和受体状态对 5 年内乳腺癌首次复发的影响(AFT-01)。
Cancer. 2023 May 1;129(9):1351-1360. doi: 10.1002/cncr.34656. Epub 2023 Mar 6.
4
Recent Progress on Therapeutic Vaccines for Breast Cancer.乳腺癌治疗性疫苗的最新进展
Front Oncol. 2022 Jun 6;12:905832. doi: 10.3389/fonc.2022.905832. eCollection 2022.
5
Understanding breast cancer as a global health concern.理解乳腺癌作为一个全球健康问题。
Br J Radiol. 2022 Feb 1;95(1130):20211033. doi: 10.1259/bjr.20211033. Epub 2021 Dec 14.
6
Molecular classification of breast cancer: A retrospective cohort study.乳腺癌的分子分类:一项回顾性队列研究。
Ann Med Surg (Lond). 2019 Dec 6;49:44-48. doi: 10.1016/j.amsu.2019.11.021. eCollection 2020 Jan.
7
Breast Cancer Statistics: Recent Trends.乳腺癌统计数据:近期趋势。
Adv Exp Med Biol. 2019;1152:1-7. doi: 10.1007/978-3-030-20301-6_1.
8
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers.人表皮生长因子受体2(Her2neu)阳性(非管腔型)原发性乳腺癌亚型的临床及预后特征:与Her2neu阳性管腔型乳腺癌的比较
BMC Res Notes. 2018 Aug 13;11(1):574. doi: 10.1186/s13104-018-3677-y.
9
Presentation of the Molecular Subtypes of Breast Cancer Detected By Immunohistochemistry in Surgically Treated Patients.手术治疗患者中通过免疫组织化学检测的乳腺癌分子亚型表现
Open Access Maced J Med Sci. 2018 Jun 6;6(6):961-967. doi: 10.3889/oamjms.2018.231. eCollection 2018 Jun 20.
10
Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania.坦桑尼亚达累斯萨拉姆穆希姆比利国家医院乳腺癌女性患者组织中激素受体和人表皮生长因子受体-2的特征分析
Infect Agent Cancer. 2017 Nov 6;12:60. doi: 10.1186/s13027-017-0170-5. eCollection 2017.

巴基斯坦信德省一家三级护理医院收治的乳腺癌患者的临床病理特征

Clinicopathological Spectrum of Breast Cancer Patients Presenting at a Tertiary Care Hospital in Sindh, Pakistan.

作者信息

Memon Sara Khalid, Hameed Faiza, Dal Nawaz A, Qureshi Mahak W, Laghari Qambar A

机构信息

Department of Surgery, Liaquat University of Medical and Health Sciences, Jamshoro, PAK.

出版信息

Cureus. 2025 Jun 17;17(6):e86249. doi: 10.7759/cureus.86249. eCollection 2025 Jun.

DOI:10.7759/cureus.86249
PMID:40693053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277851/
Abstract

Objective The objective of this study was to evaluate the various clinicopathological characteristics of breast cancer patients presenting at the Department of Surgery at Liaquat University Hospital, Jamshoro. Study design and setting A cross-sectional analytical study was conducted at the Department of Surgery, Liaquat University Hospital, Jamshoro, Pakistan, from 1 November 2024 to 30 April 2025. Methodology With a population size of around 150 patients, a margin of error of 10%, and a CI of 99%, 79 patients were asked to fill out a structured questionnaire using a consecutive sampling technique. Data were analyzed using SPSS version 16 (SPSS Inc., Chicago, IL, USA). The frequency of various clinicopathological characteristics was measured using descriptive analytics. Results A total of 79 patients were included, with a mean age of 41.94±10.85. Most women were married for more than 20 years and have breastfed their children for more than 2 years. Also, most of the patients had early menarche. The average size of the tumor was 2.08 cm, with the most common occurrence being in the upper outer quadrant (64.46%). Out of 79 patients, 36 (45.6%) had nipple retraction and 71 (89.9%) had palpable axillary lymph nodes. Metastatic disease was seen in 7 out of 79 (8.9%) patients. Among pathological parameters, 72 (91.1%) patients had intraductal carcinoma, and 50 out of 79 (63.3%) patients had a pathological grade III tumor. The majority of patients, 28 (35.4%), had estrogen receptor (ER)/progesterone receptor (PR)-positive and human epidermal growth factor receptor 2 (HER2/neu)-negative disease, whereas the second common presentation is of triple negative (ER, PR, HER2/neu) tumors, observed in 15 (19%) patients. Conclusion This study highlights the clinical and pathological parameters of breast cancer disease in patient presenting in this region of Pakistan. This will help us in developing the guidelines regarding risk factors, clinical signs, and hormonal clues present in breast cancer patients in the area of Pakistan for early diagnosis and management of breast cancer disease.

摘要

目的 本研究的目的是评估在贾姆肖罗利亚卡特大学医院外科就诊的乳腺癌患者的各种临床病理特征。

研究设计与背景 在巴基斯坦贾姆肖罗利亚卡特大学医院外科进行了一项横断面分析研究,时间为2024年11月1日至2025年4月30日。

方法 以约150名患者为总体规模,误差幅度为10%,置信区间为99%,采用连续抽样技术让79名患者填写一份结构化问卷。使用SPSS 16版(美国伊利诺伊州芝加哥市SPSS公司)对数据进行分析。使用描述性分析来测量各种临床病理特征的频率。

结果 共纳入79名患者,平均年龄为41.94±10.85岁。大多数女性结婚超过20年,且哺乳孩子超过2年。此外,大多数患者初潮早。肿瘤平均大小为2.08 cm,最常见于外上象限(64.46%)。79名患者中,36名(45.6%)有乳头凹陷,71名(89.9%)可触及腋窝淋巴结。79名患者中有7名(8.9%)出现转移性疾病。在病理参数方面,72名(91.1%)患者患有导管内癌,79名患者中有50名(63.3%)患有病理III级肿瘤。大多数患者,即28名(35.4%),患有雌激素受体(ER)/孕激素受体(PR)阳性且人表皮生长因子受体2(HER2/neu)阴性疾病,而第二常见的表现是三阴性(ER、PR、HER2/neu)肿瘤,在15名(19%)患者中观察到。

结论 本研究突出了巴基斯坦该地区就诊患者乳腺癌疾病的临床和病理参数。这将有助于我们制定关于巴基斯坦该地区乳腺癌患者存在 的危险因素、临床体征和激素线索的指南,以实现乳腺癌疾病的早期诊断和管理。